All the news Showing 9 of 9 articles from: EASL 2014Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Activism and civil society Activists protest the price of sofosbuvir: “So-Valdi, So-Expensive” – UK access already rationed i-Base / 28 May 2014 Health services, policy and advocacy Eliminating Hepatitis C Within a Generation. What are you going to do about it? You Tube / Jon Derricott / 30 April 2014 Epidemiology Viral hepatitis more deadly than HIV in Europe Science Daily / 14 April 2014 Epidemiology Viral Hepatitis More Deadly Than HIV In Europe EASL / 11 April 2014 Interferon-free regimens Merck Announces Results from Studies Evaluating Investigational Hepatitis C Treatments, MK-5172 and MK-8742, in Treatment-Naïve Patients with Genotype 1 Infection Merck press release / 11 April 2014 Finance, funding & health economics U.S. drug industry group defends price of Gilead hepatitis drug Reuters / 11 April 2014 Access to medicines & diagnostics Sofosbuvir: Gilead must commit to compassionate use & expanded access EATG / 10 April 2014 Treatment guidelines WHO issues its first hepatitis C treatment guidelines World Health Organization / 09 April 2014 Access to medicines & diagnostics WHO joins clamour to make new hepatitis C pills affordable Reuters / 09 April 2014 ← First1Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive